{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:41:12Z","timestamp":1791877272875,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1124\/dmd.112.050054","type":"journal-article","created":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T04:11:36Z","timestamp":1359778296000},"page":"897-905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":250,"title":["Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)"],"prefix":"10.1016","volume":"41","author":[{"given":"Faraz","family":"Kazmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffini","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg J.","family":"Loewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Parkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.112.050054_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10565-012-9212-3","article-title":"Cytoplasmic vacuolization during exposure to drugs and other substances","volume":"28","author":"Aki","year":"2012","journal-title":"Cell Biol Toxicol"},{"key":"10.1124\/dmd.112.050054_bib2","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1124\/dmd.112.050054_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/dmd.107.018879","article-title":"The potential influence of CO2, as an agent for euthanasia, on the pharmacokinetics of basic compounds in rodents","volume":"36","author":"Angus","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050054_bib4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/jps.22324","article-title":"The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation","volume":"100","author":"Berezhkovskiy","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.112.050054_bib5","doi-asserted-by":"crossref","first-page":"7972","DOI":"10.1073\/pnas.85.21.7972","article-title":"Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells","volume":"85","author":"Bowman","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.112.050054_bib6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1192\/apt.11.6.440","article-title":"Potentially hazardous drug interactions with psychotropics","volume":"11","author":"Chadwick","year":"2005","journal-title":"Adv Psychiatr Treat"},{"key":"10.1124\/dmd.112.050054_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/taap.1999.8688","article-title":"The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions","volume":"158","author":"Daniel","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.112.050054_bib8","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Commentary. Lysosomotropic agents","volume":"23","author":"de Duve","year":"1974","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.050054_bib9","doi-asserted-by":"crossref","first-page":"32367","DOI":"10.1074\/jbc.M400735200","article-title":"Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60","volume":"279","author":"Duvvuri","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.112.050054_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1021\/mp050043s","article-title":"A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict","volume":"2","author":"Duvvuri","year":"2005","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.112.050054_bib11","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/mp200641e","article-title":"Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction","volume":"9","author":"Funk","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.112.050054_bib12","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.4155\/bio.09.128","article-title":"Mechanisms of amine accumulation in, and egress from, lysosomes","volume":"1","author":"Goldman","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1124\/dmd.112.050054_bib13","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1124\/dmd.106.010413","article-title":"Uptake and intracellular binding of lipophilic amine drugs by isolated rat hepatocytes and implications for prediction of in vivo metabolic clearance","volume":"34","author":"Hallifax","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050054_bib14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1124\/dmd.107.015131","article-title":"Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction","volume":"35","author":"Hallifax","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050054_bib15","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.23202","article-title":"Evaluation of hepatic clearance prediction using in vitro data: emphasis on fraction unbound in plasma and drug ionisation using a database of 107 drugs","volume":"101","author":"Hallifax","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.112.050054_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx9003825","article-title":"Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds","volume":"23","author":"Hanumegowda","year":"2010","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.112.050054_bib17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1124\/dmd.108.020677","article-title":"Comparison of immortalized Fa2N-4 cells and human hepatocytes as in vitro models for cytochrome P450 induction","volume":"36","author":"Hariparsad","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050054_bib18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/bdd.616","article-title":"Lysosomal trapping of amodiaquine: impact on transport across intestinal epithelia models","volume":"29","author":"Hayeshi","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.112.050054_bib19","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1124\/dmd.112.045732","article-title":"Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes","volume":"40","author":"Jigorel","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050054_bib20","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.1014641108","article-title":"Lysosomal trapping of a radiolabeled substrate of P-glycoprotein as a mechanism for signal amplification in PET","volume":"108","author":"Kannan","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.112.050054_bib21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000137373","article-title":"Uptake of propranolol by the lung and its displacement by other drugs: involvement of the alveolar macrophage","volume":"20","author":"Kornhauser","year":"1980","journal-title":"Pharmacology"},{"key":"10.1124\/dmd.112.050054_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ab.2004.01.010","article-title":"Quantitation of the lysosomotropic character of cationic amphiphilic drugs using the fluorescent basic amine Red DND-99","volume":"327","author":"Lemieux","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.112.050054_bib23","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1517\/17425255.2012.691165","article-title":"Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications","volume":"8","author":"Logan","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.112.050054_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/bod.2510090602","article-title":"The potential role of lysosomes in tissue distribution of weak bases","volume":"9","author":"MacIntyre","year":"1988","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.112.050054_bib25","doi-asserted-by":"crossref","unstructured":"Muehlbacher M Tripal P Roas F Kornhuber J (2012). Identification of drugs inducing phospholipidosis by novel in vitro data. ChemMedChem. [published ahead of print].","DOI":"10.1002\/cmdc.201200306"},{"key":"10.1124\/dmd.112.050054_bib26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.tiv.2010.12.010","article-title":"A high content screening assay for identifying lysosomotropic compounds","volume":"25","author":"Nadanaciva","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.112.050054_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clpt.2006.09.003","article-title":"Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance","volume":"80","author":"Neuvonen","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.112.050054_bib28","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1124\/dmd.108.020479","article-title":"Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds","volume":"36","author":"Obach","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050054_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0006-2952(85)90183-2","article-title":"Inhibition of purified lysosomal phospholipase A1 by beta-adrenoceptor blockers","volume":"34","author":"Pappu","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.112.050054_bib30","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1124\/dmd.109.028274","article-title":"In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran","volume":"37","author":"Paris","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050054_bib31","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/dmd.111.038596","article-title":"An evaluation of the dilution method for identifying metabolism-dependent inhibitors of cytochrome P450 enzymes","volume":"39","author":"Parkinson","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.112.050054_bib32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/jps.22792","article-title":"In vitro-in vivo extrapolation of clearance: modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods","volume":"101","author":"Poulin","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.112.050054_bib33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbalip.2012.08.013","article-title":"Drug induced phospholipidosis: An acquired lysosomal storage disorder","volume":"1831","author":"Shayman","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.112.050054_bib34","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/jpet.103.056770","article-title":"Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs","volume":"308","author":"Siebert","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.050054_bib35","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0022-3565(25)32138-5","article-title":"Active uptake of propranolol by isolated rabbit alveolar macrophages and its inhibition by other basic amines","volume":"214","author":"Vestal","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.112.050054_bib36","doi-asserted-by":"crossref","first-page":"17707","DOI":"10.1016\/S0021-9258(19)47429-2","article-title":"Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells","volume":"266","author":"Yoshimori","year":"1991","journal-title":"J Biol Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624097083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.112.050054","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:08:20Z","timestamp":1739905700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624097083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0090955624097083"],"URL":"https:\/\/doi.org\/10.1124\/dmd.112.050054","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells)","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.112.050054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}